Latest updates for Atmp

Fresh curated links around ATMP are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells
  • EMA Accepts Otarmeni Gene Therapy for OTOF-Related Hearing Loss for Review
  • Guidance: Air Traffic Management (ATM) Equipment Approved Organization Scheme (AAOS)

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /2 weeks ago

Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells

Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune d...

Read source
hearingreview.com /1 month ago

EMA Accepts Otarmeni Gene Therapy for OTOF-Related Hearing Loss for Review

If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.

Read source
gov.uk /4 weeks ago

Guidance: Air Traffic Management (ATM) Equipment Approved Organization Scheme (AAOS)

Information for any civilian organisation wishing to undertake the provision of ATM equipment.

Read source
medcitynews.com /2 weeks ago

Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine

FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a...

Read source
webwire.com /1 month ago

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achiev...

- - • Data from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency - • Efdoralpr...

Read source
genengnews.com /2 days ago

Novel Epigenetic Therapy Targets Treatment-Resistant and TP53-Mutant AML

The results of a preclinical study across multiple models of acute myeloid leukemia found that the investigational hypomethylating agent, NTX-301 remained effective in treatment-re...

Read source
qchron.com /1 month ago

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedi...

Read source
newswire.com /4 weeks ago

Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for R...

New physician-facing platform digitizes a 30+ country network and lays the foundation for ISSCA AIâ„¢, positioning RMTG at the intersection of regenerative medicine and scalable he...

Read source
pharmexec.com /1 month ago

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Atmp

rssfeeds.webwire.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

medcitynews.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

gov.uk

Recent coverage from public sources
Public source

hearingreview.com

Recent coverage from public sources
Public source